Search results for "Rini"

showing 10 items of 746 documents

Aclidinium inhibits human lung fibroblast to myofibroblast transition

2011

Background Fibroblast to myofibroblast transition is believed to contribute to airway remodelling in lung diseases such as asthma and chronic obstructive pulmonary disease. This study examines the role of aclidinium, a new long-acting muscarinic antagonist, on human fibroblast to myofibroblast transition. Methods Human bronchial fibroblasts were stimulated with carbachol (10 −8 to 10 −5  M) or transforming growth factor-β1 (TGF-β1; 2 ng/ml) in the presence or absence of aclidinium (10 −9 to 10 −7  M) or different drug modulators for 48 h. Characterisation of myofibroblasts was performed by analysis of collagen type I and α-smooth muscle actin (α-SMA) mRNA and protein expression as well as α…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyCarbacholChronic Obstructive Pulmonary DiseaseBronchiMuscarinic AntagonistsBiologyCholinergic AgonistsCollagen Type ITransforming Growth Factor beta1Downregulation and upregulationWestern blotanticholinergicCell MovementInternal medicinemedicineCOPDHumans1506RNA MessengerAutocrine signallingFibroblastMyofibroblastsCells CulturedCell Proliferationmedicine.diagnostic_testDose-Response Relationship Drugairway epitheliumCell Differentiationasthmainterstitial fibrosisFibroblastsAdenosineMolecular biologymyofibroblastActinsUp-RegulationEndocrinologymedicine.anatomical_structurePhosphorylationFibroblastCarbacholMyofibroblastmedicine.drugTropanesThorax
researchProduct

Impact of long-term treatment with inhaled corticosteroids and bronchodilators on lung function in a patient with post-infectious bronchiolitis oblit…

2016

Post-infectious bronchiolitis obliterans (PIBO) is a small airways disease characterized by fixed airflow limitation. Therefore, inhaled bronchodilators and corticosteroids are not recommended as maintenance therapy options. The management of PIBO currently consists only of close monitoring of affected patients, aimed at the prevention and early treatment of pulmonary infections. In recent years, there has been an increase in the incidence of PIBO in the pediatric population. Patients with PIBO are characterized by a progressive decline in lung function, accompanied by a decrease in overall functional capacity. Here, we report the case of a relatively young man diagnosed with PIBO and follo…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyLong term treatmentmedicine.drug_classmedicine.medical_treatmentBronchiolitis obliteransInhaled corticosteroidsAnti-inflammatory agents/ therapeutic useCase ReportMuscarinic antagonists/therapeutic use03 medical and health sciences0302 clinical medicineAnti-inflammatory agents/therapeutic useBronchodilatormedicinePulmonary rehabilitation030212 general & internal medicineBronchiolitis obliterans/therapyLung functionGynecologylcsh:RC705-779Administration inhalationinhalationbusiness.industrylcsh:Diseases of the respiratory systemmedicine.diseaseAdministration inhalation; Adrenergic beta-2 receptor antagonists/therapeutic use; Anti-inflammatory agents/ therapeutic use; Bronchiolitis obliterans/therapy; Infection/complications; Lung diseases/rehabilitation; Muscarinic antagonists/therapeutic use; Pulmonary and Respiratory MedicineLung diseases/rehabilitation030228 respiratory systemPhysical performanceInfection/complicationAnesthesiaInfection/complicationsAdministrationbusinessAdrenergic beta-2 receptor antagonists/therapeutic usePediatric populationJornal Brasileiro de Pneumologia
researchProduct

Muscarinic M2 receptors in acetylcholine-isoproterenol functional antagonism in human isolated bronchus

2002

The muscarinic functional antagonism of isoproterenol relaxation and the contribution of muscarinic M2 receptors were examined in human isolated bronchus. In intact tissues, acetylcholine (ACh) precontraction decreased isoproterenol potency and maximal relaxation (−log EC50 shift = −1.49 ± 0.16 and Emax inhibition for 100 μM ACh = 30%) more than the same levels of histamine contraction. The M2receptor-selective antagonist methoctramine (1 μM) reduced this antagonism in ACh- but not histamine-contracted tissues. Similar results were obtained for forskolin-induced relaxation. After selective inactivation of M3 receptors with 4-diphenylacetoxy- N-(2-chloroethyl)piperadine hydrochloric acid (3…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyLung NeoplasmsPhysiologyMuscle RelaxationBronchiMuscarinic AntagonistsIn Vitro Techniqueschemistry.chemical_compoundPiperidinesPhysiology (medical)Internal medicineIsoprenalineMuscarinic acetylcholine receptorCyclic AMPmedicineMethoctramineHumansNeurotransmitterAcetylcholine receptorReceptor Muscarinic M2BronchusColforsinIsoproterenolMuscle SmoothMuscarinic acetylcholine receptor M2Cell BiologyReceptors MuscarinicAcetylcholinemedicine.anatomical_structureEndocrinologychemistryAcetylcholineMuscle Contractionmedicine.drugAmerican Journal of Physiology-Lung Cellular and Molecular Physiology
researchProduct

One-year follow up of asthmatic patients newly initiated on treatment with medium- or high-dose inhaled corticosteroid-long-acting β2-agonist in UK p…

2020

Abstract Introduction Global Initiative for Asthma (GINA) recommends medium- or high-dose inhaled corticosteroid-long-acting β2-agonist (ICS-LABA) as preferred treatments for patients with moderate-to-severe asthma. Limited data is available on how step 4/5 patients respond to ICS-LABA and how they step up/down in clinical practice. Methods This retrospective cohort study assessed the characteristics, control status, treatment pathways, and healthcare resource utilization in patients with asthma during one year after initiating medium- or high-dose ICS-LABA. Data from the United Kingdom Clinical Practice Research Datalink were analysed between January 01, 2006 and February 28, 2016. Results…

Pulmonary and Respiratory Medicinemedicine.medical_specialtybiologymedicine.drug_classLeukotriene receptorbusiness.industryAntagonistMuscarinic antagonistRetrospective cohort studyLamamedicine.diseasebiology.organism_classification03 medical and health sciences0302 clinical medicine030228 respiratory systemInternal medicineCohortmedicineCorticosteroid030212 general & internal medicinebusinessAsthmamedicine.drugRespiratory Medicine
researchProduct

Indacaterol/glycopyrronium/mometasone fixed dose combination for uncontrolled asthma

2021

INTRODUCTION Asthma symptoms can be relieved through a maintenance treatment combining long-acting β2-agonist and inhaled corticosteroids (LABA/ICS). However, for patients with inadequately controlled asthma, the LABA/ICS combination might not be sufficient. Under these conditions, clinical guidelines recommend the administration of inhaled long-acting muscarinic antagonists (LAMA) as an add-on therapy to LABA/ICS to better control asthma and improve lung function. For nearly two decades, the only LAMA to be approved on the market has been tiotropium. AREAS COVERED We reviewed recent clinical studies evaluating the safety and efficacy of LABA/LAMA/ICS fixed dose combinations by searching Pu…

Pulmonary and Respiratory Medicinemedicine.medical_specialtycorticosteroidFixed-dose combinationLABAAsthma corticosteroid fixed dose combination ICS inhaler LABA LAMA once daily combination uncontrolled asthmaMuscarinic Antagonistsonce daily combinationQuinolonesSettore MED/10 - Malattie Dell'Apparato RespiratorioinhalerAdrenal Cortex HormonesInternal medicineAdministration InhalationImmunology and AllergyMedicineHumansfixed dose combinationAdrenergic beta-2 Receptor AgonistsAsthmaFluticasonebiologyInhalationuncontrolled asthmabusiness.industryInhalerPublic Health Environmental and Occupational HealthLAMALamamedicine.diseasebiology.organism_classificationGlycopyrrolateFluticasone-Salmeterol Drug CombinationAsthmarespiratory tract diseasesDrug CombinationsICSIndansIndacaterolSalmeterolbusinessMometasone Furoatehormones hormone substitutes and hormone antagonistsmedicine.drug
researchProduct

Uno stacco verso il cielo nei territori dell'EUR

2019

La torre Eurosky, dello Studio Purini/Thermes, accarezza il cielo di Roma. Da lontano la sua grammatica espressiva sembra suggerire l’emergere di un nuovo confronto fra un’architettura realizzata e la città in divenire. Questa si colloca come elemento di forte identità in un più ampio contesto che - messo a punto in un masterplan, sempre da Purini - definisce l’intera area di progetto dell’Europarco Castellaccio, a ridosso dell’EUR. The Eurosky tower, by Studio Purini / Thermes, caresses the sky of Rome. From a distance, its expressive grammar seems to suggest the emergence of a new comparison between a completed architecture and the city in the making. This is placed as an element of stron…

Purini/Thermes architecture design identitySettore ICAR/14 - Composizione Architettonica E UrbanaPurini/Thermes progetto di architettura identità
researchProduct

Dynamics for a quantum parliament

2023

In this paper we propose a dynamical approach based on the Gorini-Kossakowski-Sudarshan-Lindblad equation for a problem of decision making. More specifically, we consider what was recently called a quantum parliament, asked to approve or not a certain law, and we propose a model of the connections between the various members of the parliament, proposing in particular some special form of the interactions giving rise to a {\em collaborative} or non collaborative behaviour.

Quantum PhysicsApplied MathematicsFOS: Physical sciencesMathematical Physics (math-ph)Quantum Physics (quant-ph)Settore MAT/07 - Fisica MatematicaMathematical PhysicsGorini–Kossakowski–Sudarshan–Lindblad equation operatorial model voting dynamics
researchProduct

Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands

2001

In our search for M2-selective muscarinic receptor antagonists, we synthesized 1,3-disubstituted indenes. The effects of different basic moieties with regard to binding and selectivity towards the five distinct muscarinic receptor subtypes were investigated. The results show that the quinuclidine series afforded the most promising compounds in terms of both receptor affinity and M2-subtype selectivity.

QuinuclidinesTertiary amineStereochemistryClinical BiochemistryPharmaceutical ScienceIn Vitro TechniquesLigandsBiochemistryChemical synthesischemistry.chemical_compoundAlzheimer DiseaseDrug DiscoveryMuscarinic acetylcholine receptorHumansReceptorMolecular BiologyAcetylcholine receptorReceptor Muscarinic M2Bicyclic moleculeOrganic ChemistryReceptors MuscarinicchemistryMolecular MedicineRadiopharmaceuticalsSelectivityTomography Emission-ComputedQuinuclidineBioorganic & Medicinal Chemistry Letters
researchProduct

Use of selected autochthonous lactic acid bacteria for Spanish-style table olive fermentation

2012

The present work presents a successful attempt to achieve an enhanced and more predictable fermentation process in Spanish-style green olive technology by selection and use of autochthonous starter cultures. During the first phase of this work, two Spanish-like fermentations of green table olives of cultivar (cv) “Nocellara del Belice”, coming from irrigated and not irrigated fields, were monitored, in order to highlight the best agricultural conditions for drupe production and to isolate lactic acid bacteria strains with relevant technological properties. Among 88 identified isolates, one Lactobacillus pentosus strain showed remarkable biochemical features and high acidification rate in sy…

RAPD-PCRChemical PhenomenaFood HandlingPopulationColony Count MicrobialLactobacillus pentosusBiologyMicrobiologychemistry.chemical_compoundStarterBriningOleaGreen table oliveFood scienceCultivareducationeducation.field_of_studybusiness.industryLactobacillus pentosufood and beveragesHydrogen-Ion Concentrationbiology.organism_classificationRandom Amplified Polymorphic DNA TechniqueLactic acidBiotechnologySettore AGR/03 - Arboricoltura Generale E Coltivazioni ArboreechemistryLactobacillaceaeFermentationGreen tables oliveFood MicrobiologySaltsFermentationbusinessBacteriaSettore AGR/16 - Microbiologia AgrariaFood ScienceFood Microbiology
researchProduct

CHIRURGIA NON INVASIVA AD ULTRASUONI FOCALIZZATI RM GUIDATI (MRGFUS) PER IL TRATTAMENTO DEI FIBROMI UTERINI SINTOMATICI: NOSTRA ESPERIENZA SULL'ELEGG…

2014

RM FIBROMI UTERINI
researchProduct